Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Challenges faced by patients in gout treatment: a qualitative study.

Singh JA.

J Clin Rheumatol. 2014 Apr;20(3):172-4. doi: 10.1097/RHU.0000000000000091. No abstract available.

2.

African American patients with gout: efficacy and safety of febuxostat vs allopurinol.

Wells AF, MacDonald PA, Chefo S, Jackson RL.

BMC Musculoskelet Disord. 2012 Feb 9;13:15. doi: 10.1186/1471-2474-13-15.

3.

Gout in the Hmong in the United States.

Wahedduddin S, Singh JA, Culhane-Pera KA, Gertner E.

J Clin Rheumatol. 2010 Sep;16(6):262-6. doi: 10.1097/RHU.0b013e3181eeb487.

4.

Uric acid lowering therapy: prescribing patterns in a large cohort of older adults.

Solomon DH, Avorn J, Levin R, Brookhart MA.

Ann Rheum Dis. 2008 May;67(5):609-13. Epub 2007 Aug 29.

PMID:
17728328
5.

More allopurinol is needed to get gout patients < 0.36 mmol/l: a gout audit in the form of a before-after trial.

Arroll B, Bennett M, Dalbeth N, Hettiarachchi D, Ben C, Shelling G.

J Prim Health Care. 2009 Dec;1(4):315-8.

PMID:
20690341
6.

Gout in Aotearoa New Zealand: are we going to ignore this for another 3 years?

Dalbeth N, Gow P, Jackson G, Shuker C, Te Karu L, Gerard C, Winnard D.

N Z Med J. 2016 Jan 29;129(1429):10-3. No abstract available.

PMID:
26914294
7.

Fenofibrate: a new treatment for hyperuricaemia and gout?

Hepburn AL, Kaye SA, Feher MD.

Ann Rheum Dis. 2001 Oct;60(10):984-6. No abstract available.

8.

The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach.

Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N.

J Clin Rheumatol. 2011 Jan;17(1):1-6. doi: 10.1097/RHU.0b013e318204a8f9.

PMID:
21169857
9.

Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.

Primatesta P, Plana E, Rothenbacher D.

BMC Musculoskelet Disord. 2011 May 20;12:103. doi: 10.1186/1471-2474-12-103.

10.

Toward development of a Tophus Impact Questionnaire: a qualitative study exploring the experience of people with tophaceous gout.

Aati O, Taylor WJ, Horne A, Dalbeth N.

J Clin Rheumatol. 2014 Aug;20(5):251-5. doi: 10.1097/RHU.0000000000000127.

PMID:
25036566
11.

Gout Self-Management in African American Veterans: A Qualitative Exploration of Challenges and Solutions From Patients' Perspectives.

Singh JA, Herbey I, Bharat A, Dinnella JE, Pullman-Mooar S, Eisen S, Ivankova N.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1724-1732. doi: 10.1002/acr.23202. Epub 2017 Sep 26.

PMID:
28118526
12.

[What is your diagnosis? Acute gout attack].

Hofmann M, Richter J, Stanga Z, Wermelinger F, Cottagnoud P, Kobel D, Stucki A.

Praxis (Bern 1994). 2006 Nov 29;95(48):1871-2. German. No abstract available.

PMID:
17176925
13.

Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.

Chohan S, Becker MA, MacDonald PA, Chefo S, Jackson RL.

Arthritis Care Res (Hoboken). 2012 Feb;64(2):256-61. doi: 10.1002/acr.20680.

14.
15.

Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout.

Tran AP, Edelman J.

Int J Rheum Dis. 2011 Aug;14(3):e33-7. doi: 10.1111/j.1756-185X.2011.01629.x.

PMID:
21816011
16.

Management of gout in primary care: challenges and potential solutions.

Dalbeth N.

Rheumatology (Oxford). 2013 Sep;52(9):1549-50. doi: 10.1093/rheumatology/ket215. Epub 2013 Jun 13. No abstract available.

PMID:
23771950
17.

[Physiopathology and treatment of gout and hyperuricemia].

Yamanaka H, Kamatani N.

Nihon Naika Gakkai Zasshi. 1999 Apr 10;88(4):718-23. Review. Japanese. No abstract available.

PMID:
10341662
18.

A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.

Khanna P, Khanna D, Storgard C, Baumgartner S, Morlock R.

Postgrad Med. 2016 Jan;128(1):34-40. doi: 10.1080/00325481.2016.1113840. Epub 2015 Nov 17.

PMID:
26578028
19.

Urate oxidase (rasburicase) for treatment of severe tophaceous gout.

Vogt B.

Nephrol Dial Transplant. 2005 Feb;20(2):431-3. No abstract available.

PMID:
15673692
20.

Patient and clinical characteristics associated with gout flares in an integrated healthcare system.

Rashid N, Levy GD, Wu YL, Zheng C, Koblick R, Cheetham TC.

Rheumatol Int. 2015 Nov;35(11):1799-807. doi: 10.1007/s00296-015-3284-3. Epub 2015 May 20.

Supplemental Content

Support Center